Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia

Medical Science Monitor

Volumn 18, Issue 6, 2012, Pages

  Szulc, Agata ^a   Galińska Skok, Beata ^a   Tarasów, Eugeniusz ^a   Konarzewska, Beata ^a   Waszkiewicz, Napoleon ^a   Hykiel, Rafał ^a   Walecki, Jerzy ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Neurocognition; Proton magnetic resonance spectroscopy; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COMPLEX FORMATION; EDUCATIONAL STATUS; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SPEECH; TEMPORAL LOBE; THALAMUS; WISCONSIN CARD SORTING TEST;

EID: 84863553797     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882909     Document Type: Article

References (51)

1. Brugger S, Davis JM, Leucht S, Stone JM: Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia A Systematic Review and Meta-Analysis. Biol Psychiatry, 2011; 69: 495-503
2. Bustillo JR, Rowland LM, Lauriello J et al: High Choline Concentrations in the Caudate Nucleus in Antipsychotic-Naïve Patients With Schizophrenia. Am J Psychiatry, 2002; 159: 130-33
3. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage, 2004; 21: 1781-89
4. 1H RS and tissue segmentation. Schizophr Res, 2001; 52: 87-99
5. Omori M, Murata T, Kiura H et al: Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res Neuroimaging, 2000; 98: 155-62
6. Ende G, Braus DF, Walter S, Henn F: Lower Concentration of Thalamic N-Acetylaspartate in Patients With schizophrenia: A Replication Study. Am J Psychiatry, 2001; 158: 1314-16
7. 1H MRS) Study. Pharmacopsychiatry, 2005; 38: 214-19
8. Callicott JH, Bertolino A, Egan MF et al: Selective Relationship Between Prefrontal N-Acetylaspartate Measures and Negative Symptoms in Schizophrenia. Am J Psychiatry, 2000; 157: 1646-51
9. Szulc A, Galinska B, Tarasow E et al: Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first episode and chronic schizophrenic patients. Psychiatr Pol, 2003; 37: 977-88
10. Choe B, Suh TS, Shin KS et al: Observation of Metabolic Changes in Chronic Schizophrenia After Neuroleptic Treatment by In Vivo Hydrogen Magnetic Resonance Spectroscopy. Investigative Radiology, 1996; 31: 345-52
11. Sigmundsson T, Maier M, Toone BK et al: Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res, 2003; 64: 63-71
12. Galinska B, Szulc A, Tarasow E et al: Relationship between frontal N-acetylaspartate and cognitive deficit in first-episode schizophrenia. Med Sci Monit, 2007; 13(Suppl.1): 11-16
13. Fukuzako H, Kodama S, Fukuzako T et al: Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy. Psychiatry Res Neuroimaging, 1999; 92: 45-56
14. Delamillieure P, Fernandez J, Constans JM et al: Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry, 2000; 157: 641-43
15. Tanaka Y, Obata T, Sassa T et al: Quantitative magnetic resonance spectroscopy of schizophrenia: Relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psych Clin Neurosci, 2006; 60: 365-72
16. Bartha R, Williamson PC, Drost DJ et al: Measurement of Glutamate and Glutamine in the Medial Prefrontal Cortex of Never-Treated Schizophrenic Patients and Healthy Controls by Proton Resonance Spectroscopy. Arch Gen Psychiatry, 1997; 54: 959-65
17. Bartha R, Al-Semaan YM, Williamson PC et al: A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol Psychiatry, 1999; 45: 1403-11
18. Bertolino A, Callicott JH, Mattay VS et al: The Effect of Treatment with Antipsychotic Drugs on Brain N-Acetylaspartate Measures in Patients with Schizophrenia. Biol Psychiatry, 2001; 49: 39-46
19. Bustillo JR, Lauriello J, Rowland LM et al: Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophr Res, 2002; 58: 313-21
20. Fannon D, Simmons A, Tennakoon L et al: Selective Deficit of Hippocampal N-Acetylaspartate in Antipsychotic-Naïve Patients with Schizophrenia. Biol Psychiatry, 2003; 54: 587-98
21. Fukuzako H: Heritability heightens brain metabolite differences in schizophrenia. J Neuropsychiatry Clin Neurosci, 2000; 12: 95-97
22. Bertolino A, Esposito G, Callicott Jh et al: Specific Relationship Between Prefrontal Neuronal N-Acetylaspartate and Activation of the Working Memory Cortical Network in schizophrenia. Am J Psychiatry, 2000; 157: 26-33
23. Delamillieure P, Constans JM, Fernandez J et al: Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results. Psychiatry Res Neuroimaging, 2004; 132: 87-89
24. Ohrmann P, Siegmund S, Suslow T et al: Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study. J Psychiatr Res, 2007; 41: 625-34
25. Ohrmann P, Kugel H, Bauer J et al: Learning potential on the WCSTin schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy. Schizophr Res, 2008; 106: 156-63
26. Shirayama Y, Obata T, Matsuzawa D et al: Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: A preliminary study. NeuroImage, 2010; 49: 2783-90
27. Szulc A, Galinska B, Tarasow E et al: Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment. Pharmacopsychiatry, 2011; 44: 148-57
28. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull, 1987; 13(2): 261-76
29. Heaton RK: Wisconsin Card Sorting Test: Computer Version 3 For Windows, Research Edition. Odessa, FL: Psychological Assessment Resources, 1990, 1993, 1999.
30. Reitan RM: The relation of the trail making test to organic brain damage. J Cons Psychol, 1958; 19: 393-94
31. Lucki W: Tests for evaluation of cognitive deficits in patients with organic brain damage. Warsaw: PTP PTP, 1995
32. Talarowska M, Florkowski A, Zboralski K, Galecki P: Cognitive functions impairment depending on clinical traits of unipolar recurrent depression preliminary results. Psychiatria i Psychoterapia, 2010; 6(1): 11-18
33. Tarasow E, Kubas B, Walecki J: MR proton spectroscopy in patients with CNS involvement In Bourneville's disease. Med Sci Monit, 2001; 7: 762-65
34. Borkowska A, Wiłkosc M, Tomaszewska M, Rybakowski J: Working memory: neurobiological and neuropsychological issues. Psychiatr Pol, 2006; 40: 383-99
35. Theberge J, Al-Semaan Y, Drost DJ et al: Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res Neuroimaging, 2004; 131: 107-14
36. Bracken BK, Jensen JE, Prescot AP et al: Brain metabolite concentrations across cortical regions in healthy adults. Brain Res, 2011; 1369: 89-94
37. Horrobin DF, Glen AIM, Vaddadi A: The membrane hypothesis of schizophrenia. Schizophr Res, 1994; 13: 195-207
38. rd ed., Elsevier, 2006; Vol. 2, 1840-907
39. Bertolino A, Ciota D, Brudaglio F et al: Working Memory Deficits and Levels of N-Acetylaspartate In patients With Schizophreniform Disorder. Am J Psychiatry, 2003; 160: 483-89
40. Ross AJ, Sachdev PS: Magnetic resonance spectroscopy in cognitive research. Brain Res Rev, 2004; 44: 83-102
41. Waldman AD, Rai GS: The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology, 2003; 45: 507-12
42. 1H MRS study of probable Alzheimer's Disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging, 1999; 17: 291-96
43. Chantal S, Labelle M, Bouchard RW et al: Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease. Arch Neurol, 2002; 59: 955-62
44. Ackl N, Ising M, Screiber YA et al: Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett, 2005; 384: 23-28
45. Chang L, Ernst T, Witt MD et al: Relationship among Brain Metabolites, Cognitive Function, and Viral Loads in Antiretroviral-Naïve HIV Patients. Neuroimage, 2002; 17: 1638-48
46. Ernst T, Chang L, Arnold S: Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage, 2003; 19: 1686-93
47. Jung RE, Haier RJ, Yeo RA: Sex differences in N-acetylaspartate correlates of general intelligence: An 1H MRS study of normal human brain. Neuroimage, 2005; 26: 965-72
48. Pfleiderer B, Ohrmann P, Suslow T et al: N-acetylaspartate levels of left frontal cortex are associated with verbal intelligence in women but not in men: a proton magnetic resonance spectroscopy study. Neuroscience, 2004; 123: 1053-58
49. Andreasen NC, Paradiso S, O'Leary DS: "Cognitive dysmetria " as an integrative theory of schizophrenia: a dysfuncion in cortical-subcorticalcerebellar circuitry? Schizophr Bull, 1998; 24: 203-18
50. Antonova E, Sharma T, Morris R, Kumari V: The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res, 2004; 70: 117-45
51. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res, 2001; 49: 1-52